Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice

Heart Rhythm

Volumn 7, Issue 11, 2010, Pages 1676-1682

  Katz, Guy ^a   Khoury, Assad ^b   Kurtzwald, Efrat ^a   Hochhauser, Edith ^a   Porat, Eyal ^a   Shainberg, Asher ^c   Seidman, Jonathan G ^d   Seidman, Christine E ^d   Lorber, Abraham ^b   Eldar, Michael ^a   Arad, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Calcium channel blocker; Human; Murine model; Sympathetic; Ventricular arrhythmia

Indexed keywords

ADRENALIN; CALSEQUESTRIN; DIHYDROPYRIDINE; FLECAINIDE; LIDOCAINE; NIFEDIPINE; PROCAINAMIDE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; EXERCISE TEST; GENE MUTATION; HEART RHYTHM; HUMAN; LOW DRUG DOSE; MALE; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TELEMETRY; TREADMILL EXERCISE;

ADOLESCENT; ADULT; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CHILD; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; PROPRANOLOL; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VERAPAMIL;

EID: 78049474416     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.07.004     Document Type: Article

References (35)

1. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients Circulation 91 1995 1512 1519
2. H. Swan, K. Piippo, and M. Viitasalo Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts J Am Coll Cardiol 34 1999 2035 2042
3. S.G. Priori, C. Napolitano, and N. Tiso Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
4. G. Katz, M. Arad, and M. Eldar Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond Curr Probl Cardiol 34 2009 9 43
5. H. Lahat, E. Pras, and T. Olender A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
6. A.V. Postma, I. Denjoy, and T.M. Hoorntje Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia Circ Res 91 2002 e21 e26
7. S.G. Priori, C. Napolitano, and M. Memmi Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69 74
8. M. Hayashi, I. Denjoy, and F. Extramiana Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119; 2009 2426 2434
9. B.C. Knollmann, N. Chopra, and T. Hlaing Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia J Clin Invest 116 2006 2510 2520
10. H. Lahat, M. Eldar, and E. Levy-Nissenbaum Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21 Circulation 103 2001 2822 2827
11. L. Song, R. Alcalai, and M. Arad Increased calreticulin and ryanodine receptors by calsequestrin-2 (CASQ2) mutations cause catecholaminergic polymorphic ventricular tachycardia J Clin Invest 117 2007 1814 1823
12. P.J. Mohler, J.J. Schott, and A.O. Gramolini Ankyrin-B mutation causes a type 4 long-QT cardiac arrhythmia and sudden death Nature 421 2003 634 639
13. X.H. Wehrens, S.E. Lehnart, and F. Huang FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise induced sudden cardiac death Cell 113 2003 829 840
14. M. Kurt, S.S. Bilge, O. Kukula, Y. Kesim, and S. Celik The role of nitrergic system in lidocaine-induced convulsion in the mouse Jpn J Pharmacol 85 2001 92 94
15. C.A. Remme, A.O. Verkerk, and D. Nuyens Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD Circulation 114 2006 2584 2594
16. M. Cerrone, B. Colombi, and M. Santoro Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor Circ Res 96 2005 77 82
17. H.J. Lee, S.Y. Berger, O. Stiedl, J. Spiess, and J.J. Kim Post-training injections of catecholaminergic drugs do not modulate fear conditioning in rats and mice Neurosci Lett 303 2001 123 126
18. B.D. Hoit, Z.U. Khan, C.M. Pawloski-Dahm, and R.A. Walsh In vivo determination of left ventricular wall stress-shortening relationship in normal mice Am J Physiol 272 1997 H1047 H1052
19. D.B. Freir, and C.E. Herron Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo Brain Res 967 2003 27 36 28
20. J. Vetulani, M. Battaglia, C. Castellano, and M. Sansone Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine Psychopharmacology (Berl) 113 1993 217 221
21. A.S. Segal, J.P. Hayslett, and G.V. Desir On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport Am J Physiol Renal Physiol 283 2002 765 770
22. S. Zhang, Z. Zhou, Q. Gong, J.C. Makielski, and C.T. January Mechanism of block and identification of the verapamil binding domain to HERG potassium channels Circ Res 84 1999 989 998
23. H.H. Valdivia, C. Valdivia, J. Ma, and R. Coronado Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum Biophysical J 58 1990 471 481
24. M.P. Blaustein, and W.J. Lederer Sodium/calcium exchange: its physiological implications Physiol Rev 79 1999 763 854
25. D. Terentyev, A. Nori, and M. Santoro Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death Circ Res 98 2006 1151 1158
26. H. Watanabe, N. Chopra, and D. Laver Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans Nat Med 15 2009 380 383
27. M.R. Di Barletta, S. Viatchenko-Karpinski, and A. Nori Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia Circulation 114 2006 1009 1012
28. M.J. Killeen, G. Thomas, I.N. Sabir, A.A. Grace, and C.L. Huang Mouse models of human arrhythmia syndromes Acta Physiol (Oxf) 192 2008 455 469
29. E.J. Whalen, J.N. Bates, A.K. Johnson, and S.J. Lewis Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis Br J Pharmacol 147 2006 755 764
30. V.V. Fedorov, and I.T. Lozinsky Is the beta3-adrenergic receptor a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death? Heart Rhythm 5 2008 298 299
31. A. Phrommintikul, and N. Chattipakorn Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death Int J Cardiol 112 2006 142 152
32. S.O. Marx, S. Reiken, and Y. Hisamatsu PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 2000 365 376
33. R. Balasubramaniam, S. Chawla, L. Mackenzie, C.J. Schwiening, A.A. Grace, and C.L. Huang Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts Pflugers Arch 449 2004 150 158
34. R. Rosso, J.M. Kalman, and O. Rogowski Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 1149 1154
35. A.A. Wilde, Z.A. Bhuiyan, and L. Crotti Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia N Engl J Med 358 2008 2024 2029